GlassScriptPhysician profile
Lloyd P Norris
NPI 1508825647
$8,835.45
in general payments reported to CMS, 2019-2025
34 companies · $958 in 2025
The $958 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,536 · 2020: $876 · 2021: $1,961 · 2022: $1,647 · 2023: $1,064 · 2024: $793 · 2025: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,815.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,307.12 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,275.27 | 2019-2025 | Leqvio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $978.72 | 2019-2024 | Jardiance |
| Amgen INC. | $854.64 | 2019-2025 | Repatha |
| Merck Sharp & Dohme LLC | $640.22 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $550.19 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $424.59 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $346.02 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $338.06 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $205.56 | 2019-2022 | |
| Baxter Healthcare | $185.19 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Alnylam Pharmaceuticals INC. | $178.32 | 2021-2025 | Amvuttra |
| Abiomed | $151.16 | 2019-2025 | |
| Esperion Therapeutics, INC. | $136.07 | 2021-2022 | |
| Boston Scientific Corporation | $131.81 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.28 | 2019-2024 | Lifevest |
| Abbott Laboratories | $116.35 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Irhythm Technologies, INC. | $108.82 | 2021-2024 | Zio Monitor, Zio Xt Patch |
| Philips North America LLC | $105.55 | 2020-2025 | (Ck4) Mcot, Ecc Solutions |
| Shockwave Medical, INC | $102.05 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $99.28 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lexicon Pharmaceuticals, INC. | $87.92 | 2023-2024 | Inpefa |
| Bridgebio Pharma, INC. | $73.35 | 2025 | Attruby |
| Kowa Pharmaceuticals America, INC. | $48.11 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $42.95 | 2025 | Opsumit, Uptravi |
| Gilead Sciences, INC. | $41.98 | 2019 | |
| Silk Road Medical, INC. | $41.00 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Inari Medical, INC. | $29.60 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $28.64 | 2025 | Cardiva Vascade 6/7f Vcs |
| Astellas Pharma US INC | $21.58 | 2019 | |
| Angiodynamics, INC. | $19.13 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $17.13 | 2019 | |
| Kestra Medical Technology Services, INC. | $16.62 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $15.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lloyd Norris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.